Blog Article
Researchers
Judith Dyson with University of Hull
Aims
- To identify barriers and facilitators to initiation and persistence of “combination” inhaler treatment among adult patients with asthma
- To identify barriers and facilitators to prescribing of “combination” inhaler treatment among health care practitioners
Asthma is an inflammatory condition effecting the airways in the lung and characterised by breathlessness, coughing, wheezing and chest tightness. “Preventer” treatment (inhaled corticosteroids) are the cornerstone of asthma treatment. “Relievers” (inhaled short acting beta-antagonists) are often given to relieve asthma symptoms if they occur. “Combination” inhalers (maintenance and reliever therapy (MART) can be used as both preventer and reliever and has been sown to reduce the risk of asthma exacerbations. A “reliever” free “combination” (MART) approach to treatment is optimal. However, delivery of and adherence with guideline recommended care is poor with both patient and practitioner. This study seeks to identify barriers and facilitators to practitioners prescribing and patients accepting “combination” inhaler treatment.
Find out more about the Centre for Social Care, Health and Related Research